OHSU

IRB #

IRB00009585

Title

Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT

Principal Investigator

Richard Maziarz

Study Purpose

The purpose of this study is to learn more about what makes related and unrelated bone marrow, blood stem cell, and umbilical cord blood transplants succeed. Samples and medical information will also be collected for use in future research studies.

Medical Condition(s)

The conditions studied in this trial will be any malignant or non-malignant blood disorder.

Eligibility Criteria

Participants must weigh at least 22 pounds and be about to receive their first bone marrow, blood stem cell, or umbilical cord blood transplant.

Age Range

01 - 99

Healthy Volunteers Needed

No

Duration of Participation

Participants will be in this study for up to two years after transplant.

Minors Included

Yes

Contact

Nan Subbiah
503-494-4603
subbiahn@ohsu.edu

Knight Clinical Trials Office Information Line
503-494-1080
trials@ohsu.edu

Sponsor

The National Institutes of Health (NIH) is sponsoring this study by providing financial support through the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

Recruitment End

Compensation Provided

No


Go Back